Cleerly ISCHEMIA vs cvi42 Auto Imaging
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if your primary focus is the non-invasive detection of coronary artery ischemia and detailed plaque characterization directly from CCTA scans. This tool is ideal for physicians seeking to precisely quantify vessel-level ischemia likelihood and assess plaque burden to inform personalized diagnosis and treatment strategies for coronary artery disease.
View Cleerly ISCHEMIA →Choose cvi42 Auto Imaging if…
Choose cvi42 Auto Imaging if you require a comprehensive, multi-modality AI-powered platform for in-depth analysis of both cardiac MR and CT images across a wide range of cardiovascular applications. This tool is best suited for clinicians needing automated contouring, advanced functional assessment (e.g., strain, flow), tissue characterization, and quantitative plaque analysis for both cardiac and vascular structures.
View cvi42 Auto Imaging →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | cvi42 Auto Imaging |
|---|---|---|
| Pricing | Unknown | Starts at $5000 per license |
| Deployment | Web-based solution | On-premise (standalone workstation or client/server) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools emphasize user-friendly interfaces and streamlined workflows. Cleerly ISCHEMIA offers a modern web-based platform with interactive reports and PowerScribe integration [cite: 1, JSON]. cvi42 Auto Imaging is praised for its unified interface across multiple modalities, intuitive design, and efficient reporting, also integrating with PowerScribe.
Clinical Value
cvi42 Auto ImagingWhile Cleerly ISCHEMIA provides highly validated, specific value in non-invasive FFR estimation and plaque characterization from CCTA, demonstrating strong diagnostic accuracy and prognostic utility, cvi42 Auto Imaging offers a broader range of clinical applications. It supports comprehensive AI-powered analysis across both MR and CT modalities, including advanced features like Strain, 4D flow, and vascular CT analysis, providing a wider diagnostic scope for cardiovascular imaging.
Pricing & Value
cvi42 Auto ImagingBoth tools have opaque pricing that requires direct contact. However, cvi42 Auto Imaging explicitly mentions a flexible subscription model that scales across CT and MR service lines, and has a newly active Category I CPT code (75577) for AI-enabled coronary plaque analysis with established reimbursement rates. This suggests a clearer path to return on investment and value for a broader range of services compared to Cleerly ISCHEMIA, which also has a CPT code (75580) for ischemia.
Enterprise Readiness
cvi42 Auto ImagingCleerly ISCHEMIA is FDA-cleared, HIPAA compliant, and provides a BAA, with web-based deployment and API integration [cite: JSON]. However, cvi42 Auto Imaging demonstrates superior enterprise readiness through its extensive global deployment in over 1,700 sites, including 70% of top hospitals, its vendor-neutral compatibility, and comprehensive integration capabilities with PACS/VNA, EMR, DICOM, HL7, and PowerScribe.
Innovation
TieBoth tools are highly innovative. Cleerly ISCHEMIA's core innovation lies in its AI-enabled non-invasive fractional flow reserve (FFR) estimation and vessel-level ischemia determination from CCTA, offering a less invasive diagnostic pathway. cvi42 Auto Imaging's innovation is in its comprehensive multi-modality platform, providing a broad suite of advanced AI-powered quantitative analyses across MR and CT, including features like Strain, 4D flow, and recent expansion into vascular CT analysis.
Support & Docs
cvi42 Auto Imagingcvi42 Auto Imaging clearly highlights its 'world-class support' with impressive customer satisfaction metrics (NPS of 69, CSAT of 4.9/5) and offers comprehensive technical support, detailed documentation, and multi-language/time-zone availability. Cleerly provides client support during business hours, but cvi42's documented commitment and performance in customer support are more robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | cvi42 Auto Imaging |
|---|---|---|
| Name | Cleerly ISCHEMIA | cvi42 Auto Imaging |
| Company | Cleerly | Circle Cardiovascular Imaging |
| Primary Modalities Analyzed | CCTA scans | Cardiovascular MR and CT images (Multi-modality support (MR, CT)) |
| Key Analysis Focus | Non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment. | AI-enabled automated contouring and segmentation, Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), Vascular CT analysis (diagnosis, planning, surveillance), Quantitative analysis (volume, mass, function, signal intensity, plaque). |
| Specialties | Cardiology, Radiology | Cardiology, Radiology, Vascular Surgery |
| Reporting Features | Comprehensive interactive web-based reports, Integration with PowerScribe via API. | Simplified and smart reporting with infographics and CAD-RADS classification. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and cvi42 Auto Imaging.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or cvi42 Auto Imaging
Backers
Who funded each tool's parent company.